MedPath

Management of Indeterminate Thyroid Nodules Across Different World Regions

Recruiting
Conditions
Indeterminate Thyroid Nodules
Interventions
Procedure: Thyroidectomy
Registration Number
NCT05851404
Lead Sponsor
University of Cagliari
Brief Summary

Thyroid carcinoma (TC) is the most common endocrine malignancy, affecting 0.2-1.5% of individuals worldwide. The rising incidence rate of TC is mostly related to the expanding use of high-quality imaging techniques, with an increase in the detection of thyroid nodules. Fine needle aspiration cytology (FNAC) is the most accurate, rapid, safe, and cost-effective test for the evaluation of thyroid nodules, with high specificity and sensitivity. Nevertheless, FNAC is particularly unreliable in differentiating between benign and malignant nodules that fall under the category of indeterminate thyroid nodules (class III and class IV according to Bethesda Classification\[2\]). In fact, in these cases, the expected malignancy rates are 5-15% and 15-30%, respectively. Thus, most patients with indeterminate thyroid nodules undergo an operation that is indeed unnecessary, while representing a risk for surgical complications and a cost for health-care systems.

We aim to evaluate different approaches to indeterminate nodules across different countries in the world.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • Patients with Bethesda III / Bethesda IV thyroid nodules
Exclusion Criteria
  • Patients with preoperative diagnosis of lymph node metastases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
South East Asian Region (SEAR)ThyroidectomyPatients that underwent thyroidectomy for indeterminate thyroid nodules in the SEAR
Americas Region (AMR)ThyroidectomyPatients that underwent thyroidectomy for indeterminate thyroid nodules in the AMR
Eastern Mediterranean Region (EMR)ThyroidectomyPatients that underwent thyroidectomy for indeterminate thyroid nodules in the EMR
the Europe Region (EUR)ThyroidectomyPatients that underwent thyroidectomy for indeterminate thyroid nodules in the EUR
Western Pacific Region (WPR)ThyroidectomyPatients that underwent thyroidectomy for indeterminate thyroid nodules in the WPR
Primary Outcome Measures
NameTimeMethod
Rate of malignancy36 months

Number of cancers over the total patients submitted to thyroidectomy for indeterminate thyroid nodules

Surgical approach to indeterminate thyroid nodules36 months

Number of lobectomies over the total patients submitted to thyroidectomy for indeterminate thyroid nodules

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AOU Cagliari

🇮🇹

Cagliari, CA, Italy

© Copyright 2025. All Rights Reserved by MedPath